Our goal is to provide as much information as possible about Lymphoma treatments.
We spend a lot of time and make great efforts to provide news as quickly as possible for the people they need most.
We only send notifications regarding important Lymphoma news.
If you want to be notified in time, then click "Ok" here and click "Allow" on the next popup box
Signup for our weekly newsletter to get the latest news, updates and amazing offers for
Kroschinsky F, et al. Invest New Drugs 2020.
The article Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.